57 related articles for article (PubMed ID: 33773263)
1. In pursuit of a selective hepatocellular carcinoma therapeutic agent: Novel thalidomide derivatives with antiproliferative, antimigratory and STAT3 inhibitory properties.
Nutt MJ; Yee YS; Buyan A; Andrewartha N; Corry B; Yeoh GCT; Stewart SG
Eur J Med Chem; 2021 May; 217():113353. PubMed ID: 33773263
[TBL] [Abstract][Full Text] [Related]
2. Structural re-positioning, in silico molecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma.
Ayoub BM; Attia YM; Ahmed MS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):858-866. PubMed ID: 29768061
[TBL] [Abstract][Full Text] [Related]
3. Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders.
Yang X; Wang Z; Pei Y; Song N; Xu L; Feng B; Wang H; Luo X; Hu X; Qiu X; Feng H; Yang Y; Zhou Y; Li J; Zhou B
Eur J Med Chem; 2021 Jun; 218():113341. PubMed ID: 33780898
[TBL] [Abstract][Full Text] [Related]
4. Effective degradation of EGFR
Qu X; Liu H; Song X; Sun N; Zhong H; Qiu X; Yang X; Jiang B
Eur J Med Chem; 2021 Jun; 218():113328. PubMed ID: 33773286
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection.
Yoshimori M; Shibayama H; Imadome KI; Kawano F; Ohashi A; Nishio M; Shimizu N; Kurata M; Fujiwara S; Arai A
Blood Adv; 2021 Apr; 5(7):1805-1815. PubMed ID: 33787860
[TBL] [Abstract][Full Text] [Related]
6. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
[TBL] [Abstract][Full Text] [Related]
7. FBX4 mediates rapid cyclin D1 proteolysis upon DNA damage in immortalized esophageal epithelial cells.
Liu J; Yang H; Cheung PY; Tsao SW; Lv L; Cheung ALM
Biochem Biophys Res Commun; 2021 May; 554():76-82. PubMed ID: 33784509
[TBL] [Abstract][Full Text] [Related]
8. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.
Sato T; Ito T; Handa H
Front Cell Dev Biol; 2021; 9():629326. PubMed ID: 33777938
[TBL] [Abstract][Full Text] [Related]
9. The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma.
Lipchick BC; Utley A; Han Z; Moparthy S; Yun DH; Bianchi-Smiraglia A; Wolff DW; Fink E; Liu L; Furdui CM; Lee J; Lee KP; Nikiforov MA
Blood Adv; 2021 Apr; 5(7):1933-1946. PubMed ID: 33821992
[TBL] [Abstract][Full Text] [Related]
10. [PX-12 Promoting Apoptosis of Multiple Myeloma Cell Line H929 Induced by Bortezomib].
Lin QD; Yan Y; Liu Q; DU JW; Gao X; Zuo WL; Fang BJ; Li YF; Wei XD; Song YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):515-519. PubMed ID: 33812423
[TBL] [Abstract][Full Text] [Related]
11. A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.
Lee HC; Feng L; Oriabure O; Graham V; Chen W; Badillo M; Lu R; Lee HJ; Jain P; Manasanch EE; Orlowski RZ; Wang ML
Am J Hematol; 2021 Jul; 96(7):E243-E246. PubMed ID: 33811767
[No Abstract] [Full Text] [Related]
12. Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells.
Roeten MSF; van Meerloo J; Kwidama ZJ; Ter Huizen G; Segerink WH; Zweegman S; Kaspers GJL; Jansen G; Cloos J
Cells; 2021 Mar; 10(3):. PubMed ID: 33802801
[TBL] [Abstract][Full Text] [Related]
13. First reported case of secondary mixed phenotype acute leukemia after multiple myeloma.
Bacchiarri F; Sammartano V; Santoni A; Raspadori D; Zappone E; Defina M; Ciofini S; Sicuranza A; Bocchia M; Gozzetti A
Am J Blood Res; 2021; 11(1):123-131. PubMed ID: 33796400
[TBL] [Abstract][Full Text] [Related]
14. Carfilzomib-Based 3-Drug Regimens for Newly Diagnosed Multiple Myeloma-All That Glitters Is Not Gold.
Hashmi H; Shah Z; Anwer F
JAMA Oncol; 2021 Jul; 7(7):967-968. PubMed ID: 33792618
[No Abstract] [Full Text] [Related]
15. The role of reversible and irreversible covalent chemistry in targeted protein degradation.
Kiely-Collins H; Winter GE; Bernardes GJL
Cell Chem Biol; 2021 Jul; 28(7):952-968. PubMed ID: 33789091
[TBL] [Abstract][Full Text] [Related]
16. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
Sriwattanakomen R; Xu Q; Demehin M; Shullo MA; Mangiola M; Hickey GW; Sciortino CM; Horn ET; Keebler ME; Zeevi A
J Heart Lung Transplant; 2021 Jul; 40(7):595-603. PubMed ID: 33785250
[TBL] [Abstract][Full Text] [Related]
17. A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination.
Vieux EF; Agafonov RV; Emerson L; Isasa M; Deibler RW; Simard JR; Cocozziello D; Ladd B; Lee L; Li H; Archer S; Fitzgerald M; Michael R; Nasveschuk CG; Park ES; Kern G; Proia DA; Phillips AJ; Fisher SL
SLAS Discov; 2021 Apr; 26(4):547-559. PubMed ID: 33780296
[TBL] [Abstract][Full Text] [Related]
18. E3 Ubiquitin Ligase UBR5 Promotes the Metastasis of Pancreatic Cancer
Li J; Zhang W; Gao J; Du M; Li H; Li M; Cong H; Fang Y; Liang Y; Zhao D; Xiang G; Ma X; Yao M; Tu H; Gan Y
Front Oncol; 2021; 11():634167. PubMed ID: 33777788
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
Abdin SM; Tolba MF; Zaher DM; Omar HA
Chem Biol Interact; 2021 May; 340():109450. PubMed ID: 33775688
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.
Plesner T; Dimopoulos MA; Oriol A; San-Miguel J; Bahlis NJ; Rabin N; Suzuki K; Yoon SS; Ben-Yehuda D; Cook G; Goldschmidt H; Grosicki S; Qin X; Fastenau J; Garvin W; Carson R; Renaud T; Gries KS
Br J Haematol; 2021 Jul; 194(1):132-139. PubMed ID: 33822368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
